Intervention Review

Benzodiazepines for schizophrenia

  1. Markus Dold1,*,
  2. Chunbo Li2,
  3. Magdolna Tardy1,
  4. Vesal Khorsand3,
  5. Donna Gillies4,
  6. Stefan Leucht1

Editorial Group: Cochrane Schizophrenia Group

Published Online: 14 NOV 2012

Assessed as up-to-date: 6 JUL 2011

DOI: 10.1002/14651858.CD006391.pub2


How to Cite

Dold M, Li C, Tardy M, Khorsand V, Gillies D, Leucht S. Benzodiazepines for schizophrenia. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD006391. DOI: 10.1002/14651858.CD006391.pub2.

Author Information

  1. 1

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  2. 2

    Shanghai Mental Health Centre, Shanghai Jiao Tong University School of Medicine, Department of Biological Psychiatry, Shanghai, China

  3. 3

    Kreisklinik München Pasing, Gynäkologisch-geburtshilfliche Abteilung, München, Germany

  4. 4

    Western Sydney and Nepean Blue Mountains Local Health Districts - Mental Health, Parramatta, NSW, Australia

*Markus Dold, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Ismaninger Straße 22, München, 81675, Germany. markus.dold@lrz.tu-muenchen.de. markus.dold@lrz.tum.de.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 14 NOV 2012

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stefan Leucht, Bartosz Helfer, Markus Dold, Werner Kissling, John McGrath, Carbamazepine for schizophrenia, The Cochrane Library,